In an effort to find ways to improve long-term outcomes for people with opioid use disorder, University of Massachusetts Amherst epidemiology researcher Elizabeth Evans set out to study the obstacles to treating this chronic condition with an effective medication, buprenorphine-naloxone.
“Very few people with opioid use disorder ever get treatment for it – 10 percent or less. Of those who do, few remain in treatment long enough to really benefit from it.”
Elizabeth Evans, assistant professor, School of Public Health and Health Sciences, University of Massachusetts Amherst.
